Switch to:
Array BioPharma, Inc. (NAS:ARRY)
Cash And Cash Equivalents
$47.19 Mil (As of Dec. 2013)

Array BioPharma, Inc.'s quarterly cash and cash equivalents increased from Jun. 2013 ($60.74 Mil) to Sep. 2013 ($65.05 Mil) but then declined from Sep. 2013 ($65.05 Mil) to Dec. 2013 ($47.19 Mil).

Array BioPharma, Inc.'s annual cash and cash equivalents increased from Jun. 2011 ($48.10 Mil) to Jun. 2012 ($55.80 Mil) and increased from Jun. 2012 ($55.80 Mil) to Jun. 2013 ($60.74 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Array BioPharma, Inc. Annual Data

Jun04Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13
BS_CashAndCashEquivalents 6.5012.4315.5710.6756.4533.2032.8548.1055.8060.74

Array BioPharma, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
BS_CashAndCashEquivalents 72.3760.3663.0355.8049.0559.5744.0060.7465.0547.19
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide